Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Ritonavir

DRUG

Stavudine

DRUG

Didanosine

Trial Locations (15)

10003

Beth Israel Med Ctr, New York

10037

Harlem Hosp Ctr, New York

14642

Univ of Rochester Med Ctr, Rochester

33311

North Broward Hosp District / HIV Clinical Research, Fort Lauderdale

33607

Saint Josephs Comprehensive Research Institute, Tampa

37212

Vanderbilt Univ School of Medicine, Nashville

70112

Louisiana State Univ Med Ctr / HIV Outpatient Clinic, New Orleans

75390

Univ of Texas Southwestern Med Ctr, Dallas

90033

Univ of Southern California, Los Angeles

90095

UCLA CARE Ctr, Los Angeles

94705

East Bay AIDS Ctr, Berkeley

02210

JSI Research and Training Institute, Boston

07103

Univ of Med & Dentistry of New Jersey, Newark

00731

Ponce Univ Hosp, Ponce

00935

Univ of Puerto Rico School of Med, Rio Piedras

Sponsors
All Listed Sponsors
lead

PPD Development, LP

INDUSTRY

NCT00006397 - Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs | Biotech Hunter | Biotech Hunter